Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOVA
3126
DELISTED
Sunnova Energy
NOVA
| $897K | ﹤0.01% |
27,241
-32,484
| -54% | -$1.15M |
|
3127
Groupon
GRPN
$1.05B
| $895K | ﹤0.01% |
39,227
+13,956
| +55% | +$413K |
|
3128
iShares US Financials ETF
IYF
$4.67B
| $895K | ﹤0.01% |
10,845
-9,782
| -47% | -$812K |
|
3129
Carter's
CRI
$1.42B
| $894K | ﹤0.01% |
9,191
-4,717
| -34% | -$476K |
|
3130
NGL Energy Partners
NGL
$2.05B
| $892K | ﹤0.01% |
376,455
+139,354
| +59% | +$272K |
|
3131
SiTime
SITM
$16B
| $892K | ﹤0.01% |
4,369
+2,557
| +141% | +$456K |
|
3132
FTI Consulting
FCN
$4.4B
| $891K | ﹤0.01% |
6,616
-4,614
| -41% | -$641K |
|
3133
Tennant Co
TNC
$1.43B
| $890K | ﹤0.01% |
12,030
-3,111
| -21% | -$233K |
|
3134
Littelfuse
LFUS
$11.2B
| $889K | ﹤0.01% |
3,252
-2,114
| -39% | -$564K |
|
3135
B2Gold
BTG
$5B
| $887K | ﹤0.01% |
259,644
-52,633
| -17% | -$203K |
|
3136
Progyny
PGNY
$2.44B
| $887K | ﹤0.01% |
15,837
+5,243
| +49% | +$290K |
|
|
PGTI
3137
DELISTED
PGT, Inc.
PGTI
| $887K | ﹤0.01% |
46,451
-4,091
| -8% | -$87.4K |
|
3138
The RealReal
REAL
$1.46B
| $886K | ﹤0.01% |
67,244
-15,182
| -18% | -$225K |
|
3139
Alto Ingredients
ALTO
$369M
| $885K | ﹤0.01% |
179,193
-148,011
| -45% | -$746K |
|
3140
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
| $885K | ﹤0.01% |
23,851
-6,197
| -21% | -$241K |
|
|
AMTI
3141
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $885K | ﹤0.01% |
34,200
-41,153
| -55% | -$1.3M |
|
|
RPT
3142
Rithm Property Trust
RPT
$95.8M
| $884K | ﹤0.01% |
10,926
+4,781
| +78% | +$384K |
|
|
NETI
3143
DELISTED
Eneti Inc.
NETI
| $883K | ﹤0.01% |
52,899
+39,804
| +304% | +$694K |
|
|
GCMGW
3144
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
| $882K | ﹤0.01% |
440,786
| – | – |
|
3145
NBT Bancorp
NBTB
$2.74B
| $881K | ﹤0.01% |
24,383
-17,379
| -42% | -$610K |
|
3146
Anika Therapeutics
ANIK
$258M
| $880K | ﹤0.01% |
20,676
-25,402
| -55% | -$1.05M |
|
3147
SelectQuote
SLQT
$132M
| $878K | ﹤0.01% |
67,912
+36,773
| +118% | +$554K |
|
3148
Teck Resources
TECK
$29.6B
| $878K | ﹤0.01% |
35,269
-1,353,662
| -97% | -$31M |
|
|
ALBO
3149
DELISTED
Albireo Pharma Inc
ALBO
| $877K | ﹤0.01% |
28,099
-18,347
| -40% | -$568K |
|
3150
Coeur Mining
CDE
$15.4B
| $875K | ﹤0.01% |
141,654
-13,278
| -9% | -$94.4K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.